Fishing Martha's 



Captain Chris Peters

But also provides essential opportunities for children to socialize throughout meals.

Kids with autism spectrum disorders more likely to have feeding problems Healthy eating not merely promotes growth and development, but also provides essential opportunities for children to socialize throughout meals. A new, comprehensive analysis of feeding behavior in children with autism spectrum disorders indicates these kids are five times much more likely to truly have a feeding problem, including extreme tantrums during meals, severe meals selectivity and ritualistic mealtime behaviors. Experts at Marcus Autism Middle and the Department of Pediatrics at Emory University College of Medication conducted a comprehensive meta-analysis of most published, peer-reviewed research associated with feeding autism and problems. Examination of dietary nutrients showed considerably lower intake of calcium and proteins and a higher number of dietary deficits overall among kids with autism.‘Our study shows how to make the changes therefore the broccoli and fish look tastier than they normally would to small Casey or little Audrey.’ The study is published in the January problem of Acta Paediatrica . Wansink and co-authors Kevin Kniffin and Mitsuru Shimizu, Cornell postdoctoral study associates; and Francesca Zampollo of London Metropolitan University, presented 23 preteen children and 46 adults with full-size photos of 48 different combinations of food on plates that varied by amount of items, placement of entr-e and organization of the food. ‘Compared with adults, children not merely prefer plates with more colors and elements, but also their entrees put into the front of the plate and with figurative designs,’ Kniffin said. ‘While a lot of the research concerning food choices among children and adults targets ‘taste, smell and chemical’ elements, we will build on findings that demonstrate that folks appear to be significantly influenced by the shape, size and visual appearance of food that is presented to them.’.

Celldex announces final results from CDX-011 Phase 2b research on GPNMB-expressing breast cancer Celldex Therapeutics, Inc.